Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CSV0C018875 is a quinoline-based EHMT2/G9a inhibitor with lower cytotoxicity than BIX-01294 [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | CSV0C018875 is a quinoline-based EHMT2/G9a inhibitor with lower cytotoxicity than BIX-01294 [1]. |
In vitro | CSV0C018875, at concentrations ranging from 2.5 to 20 μM over a 48-hour period, reduces H3K9me2 modification levels in histones [1]. Through Western Blot Analysis [1] conducted on HEK293 cells, with doses of 2.5 μM, 10 μM, and 20 μM, it was observed that CSV0C018875 progressively inhibits G9a enzymatic activity in a dose-dependent manner. |
Molecular Weight | 312.79 |
Formula | C18H17ClN2O |
CAS No. | 442150-41-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CSV0C018875 442150-41-6 inhibitor inhibit